In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study
V. Bigliani et al., In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 175, 1999, pp. 231-238
Background The dopamine hypothesis proposes that antipsychotic drugs act pr
imarily through limbic cortical D-2/D-2-like dopamine receptor blockade.
Aim To evaluate this hypothesis with the D-2/D-3-selective SPET probe [I-12
3]-epidepride.
Method [I-123]-epidepride SPET scans were performed on 12 patients with sch
izophrenia treated with antipsychotics and 11 age- matched healthy controls
. [I-123]-epidepride 'specific binding' to D-2/D-3 dopamine receptors was e
stimated, and relative percentage D-2/D-3 receptor occupancy by typical ant
ipsychotic drugs determined.
Results Mean (s.d.) daily dose was 669.12 (516.8) mg chlorpromazine equival
ents. Mean percentage D-2/D-3, receptor occupancy was 81.6 (8.1) and 73.2 (
13.9) in the temporal cortex and striatum respectively.
Conclusions Typical antipsychotic drug treatment is associated with substan
tial temporal cortical D-2/D-3 receptor occupancy. The relationship between
this and efficacy is poor in patients with treatment-resistant schizophren
ia.
Declaration of interest L.P. was supported by a Medical Research Council Cl
inician Scientist Fellowship. V.B. was supported by a research grant from E
li Lilly Pharmaceuticals.